Clinical Trial Update: Dexamethasone Study: Impact on Quality of Life of Continuing Dexamethasone Following Emetogenic Chemotherapy [Phase 3]

View source ↗

Summary

Phase 3 trial assessing whether continuing dexamethasone after emetogenic chemotherapy improves quality of life in cancer patients; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Chemotherapy-induced Nausea and Vomiting

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Cancer, Emesis | Phase 3 | Status: COMPLETED